黑料网

ISSN: 2161-0711

Journal of Community Medicine & Health Education
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Community Med Health Educ 10: 690,
  • DOI: 10.4172/2161-0711.1000690

A Preliminary Study on Various Types of 4-Aminoquinolines for Pre or Post-Exposure Prophylaxis and for Treatment in Severe Covid-19

Bright B1*, Ali W1, Fajimi N1, Adesope T1, Tairu S1, Sobande D3 and Itodo ES2
1Department of Public Health, LiveWell initiative LWI, Nigeria
2Department of Medical Laboratory Science, Niger Delta University, Wilberforce Island, Nigeria
3Department of Pediatrics, University of Wisconsin Hospitals, Dayton, Ohio, USA
*Corresponding Author : Bright B, Department of Public Health, LiveWell initiative LWI, Nigeria, Tel: 2348091769289, Email: academy@livewellng.org

Received Date: Jun 20, 2020 / Accepted Date: Jul 31, 2020 / Published Date: Aug 07, 2020

Abstract

Background: LiveWell Initiative LWI is a self-funded nonprofit social enterprise which thrives on innovation.

The organization has, for 5 years, supervised MPH and DrPH Practicums for the Harvard T. H. Chan School of Public Health, Harvard University, Boston USA. It also supervises PhD thesis at University of Helsinki, Finland. At the inception of COVID-19, LWI designed and compiled three (3) sets of study protocols in response to the COVID-19 response in Africa with a goal to arriving at a practical and affordable solution to the pandemic using 4-Aminoquinolines.

Method: A concurrent cohort/descriptive study of observation in patients exposed to HCQ/CQ Prophylaxis  and Treatment with HCQ/CQ and Quinine with categorization as specified as Not critically ill, critically ill but not on a ventilator and critically ill on a ventilator.  One hundred and twenty-three (123) subjects were categorized into shelter-in-place, self-quarantine and self-isolation (Not critically ill, critically ill but not on a ventilator and critically ill on a ventilator). The 4-Aminoquinolines were administered with macrolide and zinc sulphate as appropriate for a defined duration and doses.

Results: The preliminary study of the 123 subjects covering all categories listed above resulted in 100% positive outcomes; Nil death, Nil relapse in Symptomatic persons and Total recovery with no relapse after 6 weeks lockdown, and asymptomatic persons post-prophylaxis, after 6 weeks lockdown. The results have been gathered principally from Clinician Reported Outcomes with a few Patient Reported Outcomes.

Conclusion: These repurposed drugs with unique strengths- Chloroquine and its analogue Hydroxychloroquine as well Quinine, hold away in the treatment of COVID-19.

Keywords: 4-Aminoquinolines; Zinc Sulphate; COVID-19; Ventilator; Pandemic; Repurposing; Ionophore

Citation: Bright B, Ali W, Fajimi N, Adesope T, Tairu S, et al. (2020) A Preliminary Study on Various Types of 4-Aminoquinolines for Pre or Post- Exposure Prophylaxis and for Treatment in Severe Covid-19. J Community Med Health Educ 10: 690. Doi: 10.4172/2161-0711.1000690

Copyright: © 2020 Bright B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top